Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Uremic PruritusPruritus
Interventions
DRUG

nalbuphine HCl ER

nalbuphine HCl ER

Trial Locations (35)

11102

Newtown Dialysis Center Inc, Astoria

18017

Nephrology Research Consortium, Bethlehem

19118

Delaware Valley Nephrology, Philadelphia

19140

Dialysis Clinic, Inc., Philadelphia

27103

Brookview Hills Research Associates LLC, Winston-Salem

27609

Wake Nephrology Associates PA, Raleigh

27704

Durham Nephrology Associates, Durham

29150

Carolina Diabetes and Kidney Center, Sumter

31217

Renal Physicians of Georgia, Macon

31701

Southwest Georgia Nephrology Clinic PC, Albany

32789

DaVita Central Orlando Dialysis, Winter Park

33025

Pines Clinical Research, Pembroke Pines

33614

Genesis Clinical Research, Tampa

35211

Nephrology Associates PC, Birmingham

36617

University South Alabama Medical Center, Mobile

37408

SouthEast Renal Research Institute, Chattanooga

39648

McComb Limited Care Facility, McComb

45267

University of Cincinnati, Cincinnati

49007

Nephrology Center DBA Paragon Health, Kalamazoo

60805

Fresenius Medical Care of Evergreen Park, Evergreen Park

64131

Kidney Associates of Kansas City PC, Kansas City

71603

U.S. Renal Care Inc., Pine Bluff

76063

U.S. Renal Care Inc, Mansfield

76105

U.S. Renal Care, Inc., Fort Worth

76164

U.S. Renal Care Inc., Fort Worth

80902

Nephrology-Hypertension Associates of Central New Jersey PA, North Brunswick

83642

Pacific Renal Research Institute, Meridian

85012

Arizona Kidney Disease and Hypertension Center, Phoenix

87109

Renal Medicine Associates, Albuquerque

90606

Mark Lee MD, Inc, Whittier

91702

North America Research Institute, Azusa

93308

Pegasus Dialysis Center, Bakersfield

93309

Central Nephrology Medical Group, Bakersfield

06762

Nephrology and Hypertension Associates PC, Middlebury

01107

Western New England Renal and Transplant Association, Springfield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Trevi Therapeutics

INDUSTRY

NCT02143973 - Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus | Biotech Hunter | Biotech Hunter